IMA Fungus 12(1): e33922, doi: 10.1186/s43008-021-00075-x
A revision of malbranchea-like fungi from clinical specimens in the United States of America reveals unexpected novelty
expand article infoJose Francisco Cano-Lira, José F. Cano-Lira, Nathan Wiederhold§, Alba Pérez-Cantero, Josep Guarro, Alberto M. Stchigel
‡ Universitat Rovira i Virgili (URV), Mycology Unit, Medical School, Reus, Spain§ University of Texas Health Science Center, Fungus Testing Laboratory, San Antonio
Open Access
Abstract
The fungi of the order Onygenales can cause important human infections; however, their taxonomy and worldwide occurrence is still little known. We have studied and identified a representative number of clinical fungi belonging to that order from a reference laboratory in the USA. A total of 22 strains isolated from respiratory tract (40%) and human skin and nails (27.2%) showed a malbranchea-like morphology. Six genera were phenotypically and molecularly identified, i.e. Auxarthron/Malbranchea (68.2%), Arachnomyces (9.1%), Spiromastigoides (9.1%), and Currahmyces (4.5%), and two newly proposed genera (4.5% each). Based on the results of the phylogenetic study, we synonymized Auxarthron with Malbranchea, and erected two new genera: Pseudoarthropsis and Pseudomalbranchea. New species proposed are: Arachnomyces bostrychodes, A. graciliformis, Currahmyces sparsispora, Malbranchea gymnoascoides, M. multiseptata, M. stricta, Pseudoarthropsis crassispora, Pseudomalbranchea gemmata, and Spiromastigoides geomycoides, along with a new combination for Malbranchea gypsea. The echinocandins showed the highest in vitro antifungal activity against the studied isolates, followed by terbinafine and posaconazole; in contrast, amphotericin B, fluconazole, itraconazole and 5-fluorocytosine were less active or lacked in vitro activity against these fungi.
Keywords
Antifungals, Arachnomycetales, Auxarthron, Clinical fungi, Malbranchea, Onygenales, New taxa